0 followers
The future of infectious disease diagnostics starts at Day Zero. By using whole-genome sequencing (WGS) and the proprietary enabling technologies, Day Zero is creating a new class of sequencing-based in-vitro diagnostics that generates clinically actionable data at scale.
Jong Lee
Chembio Diagnostics
1 follower
Sight Sciences
2 followers
Stryker
114 followers
Boston Scientific
83 followers
Baxter
81 followers
Becton Dickinson
82 followers
Intuitive Surgical
41 followers
Zimmer Biomet
41 followers
Edwards Lifesciences
31 followers
Varian Medical Systems
31 followers
Dexcom
28 followers
Discover companies